Lexicon Pharmaceuticals
LXRX
#6754
Rank
HK$6.14 B
Marketcap
HK$13.81
Share price
0.57%
Change (1 day)
16.74%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -HK$0.48 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are HK$41.46 Million. In 2025 the company made an earning of -HK$0.4 Billion, an increase over its 2024 earnings that were of -HK$1.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.48 Billion20.89%
2025 -HK$0.4 Billion-74.88%
2024 -HK$1.58 Billion13.15%
2023 -HK$1.39 Billion73.74%
2022 -HK$0.8 Billion16.16%
2021 -HK$0.69 Billion49.82%
2020 -HK$0.46 Billion-147.19%
2019 HK$0.97 B-203.42%
2018 -HK$0.95 Billion-15.31%
2017 -HK$1.12 Billion0.2%
2016 -HK$1.11 Billion2920.7%
2015 -HK$36.75 Million-95.33%
2014 -HK$0.79 Billion-3.61%
2013 -HK$0.82 Billion-5.52%
2012 -HK$0.87 Billion-4.17%
2011 -HK$0.91 Billion15.5%
2010 -HK$0.79 Billion8.36%
2009 -HK$0.73 Billion-4.81%
2008 -HK$0.76 Billion28.79%
2007 -HK$0.59 Billion35.71%
2006 -HK$0.44 Billion52.91%
2005 -HK$0.29 Billion-23.89%
2004 -HK$0.38 Billion-24.19%
2003 -HK$0.5 Billion-0.48%
2002 -HK$0.5 Billion44.12%
2001 -HK$0.35 Billion23.01%
2000 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
HK$59.92 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$9.10 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$40.53 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$3.97 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$1.91 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$0.62 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-HK$0.19 Billion-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$1.17 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-HK$0.13 Billion-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA